Medical Devices Startups

BBy develops a method to shelf-stabilize and condense human breast milk without losing its nutritional or immunological properties, removing the need for freezer storage in hospital NICUs. Its product is condensed milk that stores at room temperature and is reconstituted with water, aimed at hospital neonatal intensive care units to reduce preparation time and storage costs.

2 investors

BetaGlue Therapeutics develops targeted nuclear radiotherapeutics for solid tumours, combining biotechnology, nuclear science, and interventional oncology to deliver radiation inside the tumour. Its product, YntraDose, is a Yttrium-90 microsphere radiotherapy aimed at treating pancreatic cancer and other solid tumours.

2 investors

Betaliq is a clinical-stage pharmaceutical company developing topical eye-drop therapies for glaucoma using a licensed water-free drug delivery platform (EyeSol). Its lead candidate, BTQ1902, is a timolol suspension in development for elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

2 investors

Better Medicine builds AI-powered software that detects lesions on CT scans, offering automated lesion detection, a custom imaging viewer with semi-automated measurement tools, and automated reporting for radiologists and radiology professionals. Using a multi-organ approach, the product supports cancer diagnostics by detecting primary tumors, metastases, and unidentified disease, and integrates with existing PACS and viewers.

2 investors

2 investors

Bioceptive develops women's health medical devices, including a patented FDA-approved Cervical Suction Retractor that replaces the tenaculum for gynecological procedures and an IUD inserter, offering single-use disposable instruments aimed at reducing pain during transcervical procedures. It serves healthcare professionals in the U.S. and developing regions, and is based in New Orleans, Louisiana.

2 investors

BioCorteX develops personalized therapeutics using a microbiome knowledge graph and proprietary biology emulation platform to tailor drug treatments for diverse populations. The company aims to improve treatment efficacy across different communities by accounting for individual microbiome variations in drug development.

2 investors

BioEclipse Therapeutics is a clinical-stage oncology company developing immuno-oncology therapeutics using a proprietary platform that targets the tumor microenvironment through engineered immune cell therapies. The company's approach combines multiple mechanisms of action to eradicate cancer cells and generate durable immune responses against relapse and recurrence.

2 investors

BioGrip develops non-invasive neuromuscular sensing technology combined with adaptive AI to decode human intention and enable intuitive control of prosthetics, rehabilitation systems, and robotics. The company targets individuals with mobility impairments and muscular or peripheral nerve damage.

2 investors

Bioherent develops label-free biosensors using integrated silicon photonics, surface chemistry, and nanomaterials for in vitro diagnostics, with its AllerWAVE tabletop analyzer and disposable cartridges detecting antibiotic allergies and anaphylaxis for hospitals and labs. It also sells custom silica nanoparticles (NanoKit) for biomedical research and licenses OEM photonic biosensor modules for third-party diagnostic and monitoring platforms.

2 investors

BioLattice develops engineered cornea tissue as an alternative to donor cornea for patients with corneal blindness and those waiting for transplants. The company focuses on tissue engineering to address the shortage of donor cornea supply in the global ophthalmology market.

2 investors

BiomeBank develops microbiome-based therapies aimed at restoring the gut microbial ecosystem, with a focus on conditions such as inflammatory bowel disease and Clostridioides difficile infection. The company operates a cGMP manufacturing facility in Adelaide and works with academic and hospital research partners on drug discovery and clinical development.

2 investors

biomodal develops a multi-modal genomic sequencing platform, including its 6-base sequencing and duet evoC products, that profiles epigenetic (5mC, 5hmC), genetic, and fragmentomics biomarkers from a single DNA sample. Its technology is applied to liquid biopsy workflows for applications such as cancer detection.

2 investors

Biomotum develops wearable robotic systems for gait rehabilitation that assist individuals with neurological impairments such as cerebral palsy and stroke. The technology is designed for clinical use and aims to improve walking function and patient mobility outcomes.

2 investors

Bionic Power makes the Agilik smart orthosis, a powered knee brace that helps children and adults with knee-related gait deficiencies such as flex knee gait (from cerebral palsy or spina bifida) and lower limb hemiparesis (post-stroke or post-polio). The device assists with extending and flexing the knee to improve endurance and independence.

2 investors

BioRegenMed is a high-tech company developing biomedical materials for trauma repair and tissue regeneration. The company manufactures and sells biomimetic tissue repair and regeneration products for clinical use globally.

2 investors

BioSerenity develops and manufactures CE- and FDA-approved electrophysiological medical devices, AI, and software to capture and analyze EEG, ECG, and PSG signals for diagnosing neurological and cardiac disorders. It serves clinics and medical centers, providing AI-assisted neurophysiological diagnostics.

2 investors

Biotheryx is a clinical-stage biopharmaceutical company developing first-in-class targeted protein degraders, including molecular glues and bifunctional degraders, with an initial focus on cancer and inflammatory disease. Its drug discovery work is built on modulating Cereblon and its proprietary PRODEGY platform.

2 investors

Biotts develops transdermal drug delivery products using its proprietary MTC-Y carrier system, a semisolid emulsion that transports both lipophilic and hydrophilic molecules up to 6,000 Da (including peptides and proteins) through the skin. The company creates its own transdermal drug products and licenses its technology and development expertise to the pharmaceutical industry.

2 investors

Blocksynop develops the Neural Blockade Monitor, a noninvasive, real-time device for measuring the effectiveness of local anesthetics (neural blocks) in patients. The tool is intended for anesthesiologists and clinical pain management, combining biomedical and systems engineering.

2 investors

Body Vision Medical develops LungVision, an AI-driven imaging and navigation system that turns a 2D C-arm into a 3D imaging tool to help pulmonologists and thoracic surgeons locate and biopsy small lung lesions in real time. Its AI Tomo technology corrects for CT-to-Body divergence to improve diagnostic yield in lung cancer bronchoscopy and the delivery of localized therapies.

2 investors

BondTrue develops medical devices through design and development services. The company serves medical device manufacturers and is funded by the National Science Foundation.

2 investors

BONESUPPORT is an orthobiologics company that develops and markets CERAMENT, a line of injectable, radiopaque, osteoconductive and drug-eluting bioceramic products that remodel into host bone. Its products treat fractures and bone voids caused by trauma, infection, disease, or related surgery.

2 investors

BPEndo develops a medical device designed to prevent air and fluid incontinence during colonoscopy procedures, improving exam quality and patient safety for gastroenterologists and healthcare facilities.

2 investors